Pikumil Pikumil
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Reels
  • Blogs
  • Offres
  • Emplois
  • Courses
  • Forums
  • Film
  • Jeux
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Akshay Gorde Ajouter une nouvelle offre d'emploi Health
    2026-09-18 14:20:36 -
    Acinetobacter Pneumonia Therapeutics Market Growth is booming worldwide Analysis By Fact.MR
    ROCKVILLE, MARYLAND , Sept 18, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound annual growth rate (CAGR) of 6.6%. The market reached USD 790.4 million in 2025. Absolute opportunity over the forecast period totals USD 754.0 million. The market covers...
    0 Commentaires 0 Parts 61 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Akshay Gorde Ajouter une nouvelle offre d'emploi Health
    2026-08-25 13:21:54 -
    Acinetobacter Pneumonia Therapeutics Market Growth, Key Players, SWOT, Revenue Analysis Analysis By Fact.MR
    U.S. Acinetobacter Pneumonia Therapeutics Market Sees Pfizer Driving Innovation as Global Market Expands from USD 842.6 million in 2026 to USD 1,596.6 million by 2036 at a 6.6%. CAGR ROCKVILLE, MARYLAND , August 25, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound...
    0 Commentaires 0 Parts 225 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Priyanka Bhingare Ajouter une nouvelle offre d'emploi Autre
    2025-12-18 07:53:40 -
    Global Acinetobacter Pneumonia Therapeutics Market Analysis
    The Global Acinetobacter Pneumonia Therapeutics Market Size Was Valued at USD 614.6 Million in 2023 and is Projected to Reach USD 1003.6 Million by 2032, Growing at a CAGR of 5.6% From 2024-2032. Acinetobacter pneumonia therapeutics encompass a specialized range of medical treatments and pharmaceutical interventions designed to combat infections caused by Acinetobacter baumannii, a formidable...
    0 Commentaires 0 Parts 802 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2026 Pikumil French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Bengali
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire